Navigation Links
China Sky One Medical, Inc. Receives Scientific Achievement Award
Date:12/29/2008

HARBIN, China, Dec. 29 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), announced today that it was awarded Science and Technology Prize by Shandong Province for its Naftopidil Dispersible Tablet, a new drug developed by its wholly-owned subsidiary Peng Lai Jin Chuang Pharmaceutical Company (Jin Chuang).

Naftopidil Dispersible Tablets are intended for the treatment of enlarged prostate in men and can be easily absorbed and digested by the human body. Jin Chuang has taken five years to research and develop the Naftopidil Dispersible Tablet. Currently, the tablet can only be produced by Jin Chuang and it is expected to be launched in China early 2009.

"China Sky One Medical is honored to receive such a prestigious award which was widely recognized throughout China," said Mr. Yan-Qing Liu, Chairman and CEO of China Sky One Medical. "In China, there is a huge potential market for drugs that treat enlarged prostate in men and we forecast that the sales of Naftopidil Dispersible Tablets will help us achieve higher revenues in 2009."

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR"), Harbin First Bio- Engineering Company Limited ("First"), Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong") and Peng Lai Jin Chuang Pharmaceutical Company ("Jin Chuang") the Company manufactures and distributes over-the-counter pharma
'/>"/>

SOURCE China Sky One Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. China Medicine to Distribute Dental and Surgical Instruments
2. HUYA Bioscience Announces Agreement to Provide Schering-Plough With Drug Development Candidates From China
3. VIASPACE Plants Biofuel & Animal Feed Grass and Signs Land Lease in China
4. China Sky One Medical, Inc. Interviewed in The China Perspective
5. China Medicine Corporation Awarded GSP Certification
6. NSD Bio Group, LLC chosen by U.S.-China Economic & Security Review Commission for Report on Chinas High Tech Sectors
7. China Medical Technologies Completes the Development of EGFR Molecular Diagnostic Kits
8. China Sky One Medical, Inc. Obtains Production Rights for Nine New Drugs
9. China Biologic Products Reports Strong Third Quarter 2008 Results
10. NYSE Alternext US Accepts China Shenghuos Compliance Plan for Continued Listing
11. China Medical Technologies Receives SFDA Approval for Breast Cancer HER-2 FISH Probe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 This webinar ... on nonclinical and clinical safety assessment in biosimilars. ... guide a path for biosimilar drug development, however ... of biosimilarity with regards to quality, safety and ... of biosimilar drug development and registration, development strategies ...
(Date:1/15/2014)... NC (PRWEB) January 15, 2014 ... an enhancement to its Online Web Portal for Life ... now have the ability to specify the subject matter ... nearly 50 life science sub-domains. This will help reduce ... and scientific fields, and decrease the likelihood of error. ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 ... – 11 p.m. , Location: Warrington Country Club, 1360 ... Hepatitis B Foundation, the only national nonprofit organization solely ... improving the quality of life for those affected worldwide, ... 11 at Warrington Country Club in Warrington, Pa. ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... initiated coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua ... and marketing proprietary products to serve the wound ... , In late 2012, Alliqua was restructured ... launched the company’s new strategy to become a ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... ARIUS Research Inc., (TSX:,ARI), a biotechnology company ... therapeutics, today announced its financial and operational,results ... ended May 31st, 2008., "Throughout the ... moving,ARIUS, anti-cancer antibodies towards human clinical trial. ...
... , The white blood cells in our body combat ... leukemia, the formation of white blood cells is disturbed: ... multiply out of control without fully maturing. This process ... more susceptible to infections. T-ALL, a particular form of ...
... electronic device is an important step toward helping astronomers ... universe. This invisible light makes up 98% of the ... insights into the earliest stages of star and galaxy ... new circuit, developed by physicsts at Rutgers University, NASA,s ...
Cached Biology Technology:ARIUS announces second quarter fiscal 2008 financial results 2ARIUS announces second quarter fiscal 2008 financial results 3ARIUS announces second quarter fiscal 2008 financial results 4ARIUS announces second quarter fiscal 2008 financial results 5ARIUS announces second quarter fiscal 2008 financial results 6ARIUS announces second quarter fiscal 2008 financial results 7ARIUS announces second quarter fiscal 2008 financial results 8ARIUS announces second quarter fiscal 2008 financial results 9ARIUS announces second quarter fiscal 2008 financial results 10ARIUS announces second quarter fiscal 2008 financial results 11ARIUS announces second quarter fiscal 2008 financial results 12ARIUS announces second quarter fiscal 2008 financial results 13ARIUS announces second quarter fiscal 2008 financial results 14ARIUS announces second quarter fiscal 2008 financial results 15Not the protein, but its location in the cell, determines the onset of leukemia 2Nano-sized electronic circuit promises bright view of early universe 2Nano-sized electronic circuit promises bright view of early universe 3
(Date:4/14/2014)... if you,re over 24 years of age you,ve already ... performance, according to a new Simon Fraser University study. ... associate professor Mark Blair, Thompson,s thesis supervisor, and Andrew ... the news in a just-published PLOS ONE ... social science experiments to rest on big data, the ...
(Date:4/14/2014)... in the Puerto Rican climate over the past three ... coqui frog, the territory,s national animal. UCLA biologists have ... but their mating call has also become shorter and ... UCLA distinguished professor of integrative biology and physiology and ... UCLA physics researcher, the study examined 170 male coqui ...
(Date:4/14/2014)... face the decision of whether to get a ... decision can be even more challenging. Now, a ... decisions in families of children with autism and ... parents reported the benefits of dog ownership included ... to learn responsibility. , "Children with autism spectrum ...
Breaking Biology News(10 mins):Study says we're over the hill at 24 2Climate change a likely culprit in coqui frog's altered calls, say UCLA biologists 2Dog ownership benefits families of children with autism, MU researcher finds 2
... approved for use by the U.S. Food and Drug ... the growth and invasiveness of ovarian cancer cells and ... UCLA,s Jonsson Comprehensive Cancer Center found. The drug, ... effective in fighting ovarian cancer in cell lines in ...
... NEW YORK and LAS VEGAS, Nov. 9 CBS ... an Omnicom Media Group company, today announced a new research partnership ... research facility housed in the MGM Grand Hotel in Las Vegas. ... Vision with one of the county,s leading agencies, will be called ...
... wet ethanol production method that begins by soaking corn ... of ethanol and more usable co-products, giving ethanol producers ... 20 percent. "The conventional ethanol production method has ... soluble, it doesn,t have any other co-products," said University ...
Cached Biology News:FDA approved leukemia drugs shows promise in ovarian cancer cells 2CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 2CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 3CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 4Wet ethanol production process yields more ethanol and more co-products 2
... (eIF4E-binding protein II) is involved in translation ... kidney. PHAS proteins bind to eIF-4E, the ... capped mRNA in vitro and in cells. ... of PHAS/eIF-4E complexes. This allows eIF-4E to ...
... 2 (VMAT2). An antibody made to the ... at ~55 kDa in postnuclear supernatants of ... wild type cells (2). Some additional bands, ... also detected and remain unaffected by the ...
... Anti-Matrix Metalloproteinase-2, Hinge Region By immunoblotting ... native protein. It reacts with free MMP-2 ... antibody buffered aqueous glycerol solution ... pH 7.4, containing 50% glycerol and 15 ...
Acetylcholinesterase from human and monkey....
Biology Products: